You are here
Role of Polyunsaturated Fat in Modifying Cardiovascular Risk Associated With Family History of Cardiovascular Disease: Pooled De Novo Results From 15 Observational Studies.
Thursday,2024-02-01 21:44 America/Los_Angeles — ecterry
| Title | Role of Polyunsaturated Fat in Modifying Cardiovascular Risk Associated With Family History of Cardiovascular Disease: Pooled De Novo Results From 15 Observational Studies. |
| Publication Type | Journal Article |
| Year of Publication | 2024 |
| Authors | Laguzzi, F, Åkesson, A, Marklund, M, Qian, F, Gigante, B, Bartz, TM, Bassett, JK, Birukov, A, Campos, H, Hirakawa, Y, Imamura, F, Jäger, S, Lankinen, M, Murphy, RA, Senn, M, Tanaka, T, Tintle, N, Virtanen, JK, Yamagishi, K, Allison, M, Brouwer, IA, de Faire, U, Eiriksdottir, G, Ferrucci, L, Forouhi, NG, Geleijnse, JM, Hodge, AM, Kimura, H, Laakso, M, Riserus, U, van Westing, AC, Bandinelli, S, Baylin, A, Giles, GG, Gudnason, V, Iso, H, Lemaitre, RN, Ninomiya, T, Post, WS, Psaty, BM, Salonen, JT, Schulze, MB, Tsai, MY, Uusitupa, M, Wareham, NJ, Oh, S-W, Wood, AC, Harris, WS, Siscovick, D, Mozaffarian, D, Leander, K |
| Corporate/Institutional Authors | Fatty Acids and Outcomes Research Consortium (FORCE) |
| Journal | Circulation |
| Volume | 149 |
| Issue | 4 |
| Pagination | 305-316 |
| Date Published | 2024 Jan 23 |
| ISSN | 1524-4539 |
| Keywords | Animals, Biomarkers, Cardiovascular Diseases, Docosahexaenoic Acids, Fatty Acids, Omega-3, Risk Factors |
| Abstract | <p><b>BACKGROUND: </b>It is unknown whether dietary intake of polyunsaturated fatty acids (PUFA) modifies the cardiovascular disease (CVD) risk associated with a family history of CVD. We assessed interactions between biomarkers of low PUFA intake and a family history in relation to long-term CVD risk in a large consortium.</p><p><b>METHODS: </b>Blood and tissue PUFA data from 40 885 CVD-free adults were assessed. PUFA levels ≤25th percentile were considered to reflect low intake of linoleic, alpha-linolenic, and eicosapentaenoic/docosahexaenoic acids (EPA/DHA). Family history was defined as having ≥1 first-degree relative who experienced a CVD event. Relative risks with 95% CI of CVD were estimated using Cox regression and meta-analyzed. Interactions were assessed by analyzing product terms and calculating relative excess risk due to interaction.</p><p><b>RESULTS: </b>After multivariable adjustments, a significant interaction between low EPA/DHA and family history was observed (product term pooled RR, 1.09 [95% CI, 1.02-1.16]; =0.01). The pooled relative risk of CVD associated with the combined exposure to low EPA/DHA, and family history was 1.41 (95% CI, 1.30-1.54), whereas it was 1.25 (95% CI, 1.16-1.33) for family history alone and 1.06 (95% CI, 0.98-1.14) for EPA/DHA alone, compared with those with neither exposure. The relative excess risk due to interaction results indicated no interactions.</p><p><b>CONCLUSIONS: </b>A significant interaction between biomarkers of low EPA/DHA intake, but not the other PUFA, and a family history was observed. This novel finding might suggest a need to emphasize the benefit of consuming oily fish for individuals with a family history of CVD.</p> |
| DOI | 10.1161/CIRCULATIONAHA.123.065530 |
| Alternate Journal | Circulation |
| PubMed ID | 38047387 |
| PubMed Central ID | PMC10798593 |
ePub date:
23/12